|
Quotes & Info
|
| CRL > SEC Filings for CRL > Form 8-K on 8-Jan-2013 | All Recent SEC Filings |
8-Jan-2013
Regulation FD Disclosure, Financial Statements and E
The following information (including Exhibit 99.1) shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
On January 7, 2013, Charles River Laboratories International, Inc. (the "Registrant" or "Charles River") issued a press release which announced that it had closed the acquisition of Vital River, the premier commercial provider of research models and related services in China. In addition, the Registrant will be presenting at the J.P. Morgan 31st Annual Healthcare Conference in San Francisco, California, on Tuesday, January 8 th , at 10:00 a.m. PT (1:00 p.m. ET). Management of the Registrant intends to present an overview of the Registrant's strategic focus and business developments. Included in this overview will be information related to the effect of the Vital River acquisition on Charles River's 2013 guidance. In advance of the presentation, the Registrant has posted the accompanying slide presentation on the Investor Relations section of the Registrant's website. In addition, a copy of the slide presentation is incorporated herein by reference and filed as Exhibit 99.1 hereto.
The slide presentation, attached as an exhibit to this report, includes "safe harbor" language pursuant to the Private Securities Litigation Reform Act of 1995, as amended, indicating that certain statements contained in the slide presentation are "forward-looking" rather than historic. The slide presentation also states that these and other risks relating to Charles River are set forth in the documents filed by Charles River with the Securities and Exchange Commission.
(a) Not applicable.
(b) Not applicable.
(c) Exhibits.
99.1 J.P. Morgan 31st Annual Healthcare Conference Slide Presentation, dated January 8, 2013
|
|